Analyst Consensus ?
ConsensusBuy36 ratings
Bullish2466.7%
Neutral1130.5%
Bearish12.8%
Equifax Inc. · EFX · FY2025 Q2 · Calendar Q3 2025
Equifax posts record Q2 revenue as cloud momentum offsets rising risks
The supplied analysis supports a constructive but qualified view: resilient mortgage and non-mortgage demand, cloud migration, new data products, and government verification opportunities can support growth, while funding volatility, hiring weakness, litigation, FX, and mortgage competition argue against treating the trajectory as low risk.
Reported Before market openNYSEIndustrials
$16.45B market cap
90quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$2.00
Consensus $1.93
EPS surprise
+3.6%
Reported versus consensus
Reported revenue
$1.54B
Consensus $1.51B
Revenue surprise
+1.6%
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
-8.2%
Event window
SPY move
+0.0%
Same window
Abnormal move
-8.2%
Stock minus SPY
Volume
2.6×
Versus trailing sessions
Subsequent drift
+4.8%
Up to 20 sessions
EFXSPY benchmark
Ask FN2 about EFX FY2025 Q2
Transcript, numbers and history already loaded
Why did EFX fall 8.2% after beating EPS estimates in FY2025 Q2?What changed in EFX's guidance and outlook in FY2025 Q2?Give me the bull and bear case for EFX after FY2025 Q2 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Management maintained FY25 guidance, raised the 2025 vitality outlook to 12%, and highlighted twin-indicator, AI analytics, government verification, and international opportunities. The analysis also identifies higher litigation costs and near-term government-revenue volatility as more prominent constraints.
Guidance delta
Management maintained FY25 guidance and raised its 2025 vitality outlook to 12%.
Key takeaways
- Management described record Q2 revenue, supported by mortgage growth and solid non-mortgage performance.
- USIS post-cloud vitality reached 10%, while adjusted EBITDA margin improved to 35.5% year over year.
- Twin-indicator products, EFX.ai, government verification, and international demand are the main growth avenues.
- Government funding volatility, hiring weakness, litigation costs, FX, and mortgage competition remain key risks.
Management priorities
- Extend cloud migration and use the resulting cost efficiencies to accelerate new-product development
- Launch twin-indicator products for auto and P-loans and expand income-verification offerings
- Pursue government verification opportunities and flexible subscription pricing
- Continue international expansion and share repurchases
Follow EFX with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$140Current
$148Low
$241.71Average
$331High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 3, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Barclays | Equal Weight | Equal Weight | Maintain | Oct 2, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Sep 30, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Sep 22, 2026 |
| Rothschild & Co | Buy | Neutral | Upgrade | Aug 21, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jul 22, 2026 |
| Needham | Buy | Buy | Maintain | Jul 22, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jul 22, 2026 |
| Baird | Outperform | Outperform | Maintain | Jul 22, 2026 |
| UBS | Buy | Buy | Maintain | Jul 8, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Jul 2, 2026 |
| B of A Securities | Buy | Buy | Maintain | May 19, 2026 |
| Goldman Sachs | Neutral | Neutral | Maintain | Feb 9, 2026 |
| Stifel | Buy | Buy | Maintain | Feb 5, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Feb 5, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Jan 12, 2026 |
| Citigroup | Buy | Buy | Maintain | Jul 23, 2025 |
| Jefferies | Buy | Buy | Maintain | Jan 15, 2025 |
| Exane BNP Paribas | Outperform | Neutral | Upgrade | Dec 16, 2024 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Dec 12, 2024 |
| Evercore ISI Group | Outperform | In Line | Upgrade | Feb 13, 2024 |
| Truist Securities | Buy | Buy | Maintain | Feb 9, 2024 |
| Redburn Atlantic | Neutral | Buy | Downgrade | Jan 11, 2024 |
| Deutsche Bank | Buy | Hold | Upgrade | Dec 8, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Jul 21, 2023 |
| Atlantic Equities | Overweight | Neutral | Upgrade | Nov 15, 2022 |
| Argus Research | Buy | Hold | Upgrade | Oct 22, 2021 |
| SunTrust Robinson Humphrey | Hold | Buy | Downgrade | Jun 9, 2020 |
| CFRA | Hold | Hold | Maintain | Apr 21, 2020 |
| Stifel Nicolaus | Hold | Hold | Maintain | Feb 18, 2020 |
| Bank of America | Underperform | Underperform | Maintain | Oct 2, 2019 |
| Stephens & Co. | Equal Weight | Equal Weight | Maintain | Jul 26, 2019 |
| Argus | Hold | Hold | Maintain | Sep 15, 2017 |
| William Blair | Outperform | Outperform | Maintain | Apr 8, 2016 |
| Cowen & Co. | Outperform | Outperform | Maintain | Mar 30, 2016 |
| Raymond James | Market Perform | Outperform | Downgrade | Feb 18, 2014 |
| Evercore Partners | Overweight | Equal Weight | Upgrade | Feb 19, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $140. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Goldman Sachs | George Tong | $148 | $139.73 | +5.7% | Oct 2, 2026 |
| Barclays | Analyst unavailable | $155 | $139.73 | +10.7% | Oct 2, 2026 |
| Credit Suisse | Analyst unavailable | $160 | $140.83 | +14.3% | Sep 30, 2026 |
| Goldman Sachs | George Tong | $171 | $145.78 | +22.1% | Sep 29, 2026 |
| Wells Fargo | Jason Haas | $200 | $158.62 | +42.9% | Sep 22, 2026 |
| BNP Paribas | Andrew Grobler | $245 | $177.05 | +75.0% | Sep 8, 2026 |
| Redburn Partners | Simon Clinch | $235 | $192.41 | +67.9% | Aug 21, 2026 |
| Deutsche Bank | Analyst unavailable | $208 | $169.84 | +48.6% | Jul 22, 2026 |
| Needham | Kyle Peterson | $245 | $173 | +75.0% | Jul 22, 2026 |
| Wells Fargo | Jason Haas | $212 | $173 | +51.4% | Jul 22, 2026 |
| Morgan Stanley | Analyst unavailable | $225 | $173 | +60.7% | Jul 22, 2026 |
| Robert W. Baird | Analyst unavailable | $232 | $173 | +65.7% | Jul 22, 2026 |
| Barclays | Analyst unavailable | $200 | $173 | +42.9% | Jul 22, 2026 |
| RBC Capital | Ashish Sabadra | $194 | $173 | +38.6% | Jul 22, 2026 |
| Goldman Sachs | George Tong | $182 | $173 | +30.0% | Jul 21, 2026 |
| Mizuho Securities | Analyst unavailable | $210 | $167.22 | +50.0% | Jul 2, 2026 |
| Goldman Sachs | George Tong | $173 | $151.93 | +23.6% | Jun 26, 2026 |
| Wells Fargo | Analyst unavailable | $220 | $154.84 | +57.1% | Jun 18, 2026 |
| UBS | Analyst unavailable | $215 | $165.13 | +53.6% | Jun 16, 2026 |
| UBS | Kevin McVeigh | $220 | $176.38 | +57.1% | Apr 23, 2026 |
| Mizuho Securities | Analyst unavailable | $222 | $186.85 | +58.6% | Apr 16, 2026 |
| Goldman Sachs | Analyst unavailable | $208 | $193.55 | +48.6% | Feb 6, 2026 |
| RBC Capital | Ashish Sabadra | $222 | $188.19 | +58.6% | Feb 5, 2026 |
| Needham | Analyst unavailable | $265 | $184.57 | +89.3% | Feb 5, 2026 |
| Stifel Nicolaus | Analyst unavailable | $235 | $184.63 | +67.9% | Feb 5, 2026 |
| RBC Capital | Analyst unavailable | $220 | $183.44 | +57.1% | Feb 5, 2026 |
| BMO Capital | Analyst unavailable | $195 | $181.04 | +39.3% | Feb 5, 2026 |
| Robert W. Baird | Analyst unavailable | $250 | $181.04 | +78.6% | Feb 5, 2026 |
| UBS | Analyst unavailable | $230 | $181.04 | +64.3% | Feb 5, 2026 |
| Barclays | Manav Patnaik | $215 | $181.04 | +53.6% | Feb 5, 2026 |
| Morgan Stanley | Toni Kaplan | $244 | $181.04 | +74.3% | Feb 4, 2026 |
| Morgan Stanley | Analyst unavailable | $280 | $220.77 | +100.0% | Dec 17, 2025 |
| BMO Capital | Analyst unavailable | $234 | $211.51 | +67.1% | Dec 8, 2025 |
| BMO Capital | Analyst unavailable | $245 | $229.93 | +75.0% | Oct 22, 2025 |
| Stifel Nicolaus | Analyst unavailable | $253 | $231.31 | +80.7% | Oct 22, 2025 |
| Wells Fargo | Analyst unavailable | $285 | $228.33 | +103.6% | Oct 15, 2025 |
| Oppenheimer | Analyst unavailable | $271 | $230.81 | +93.6% | Oct 13, 2025 |
| UBS | Analyst unavailable | $297 | $256.25 | +112.1% | Sep 15, 2025 |
| UBS | Kevin McVeigh | $278 | $243.56 | +98.6% | Jul 23, 2025 |
| Bank of America Securities | Joshua Dennerlein | $285 | $255.08 | +103.6% | Jun 23, 2025 |
| RBC Capital | Ashish Sabadra | $300 | $243.45 | +114.3% | Mar 20, 2025 |
| BNP Paribas | Andrew Grobler | $305 | $260.55 | +117.9% | Dec 16, 2024 |
| Citigroup | Arthur Truslove | $331 | $285.2 | +136.4% | Oct 11, 2024 |
| BNP Paribas | Andrew Grobler | $310 | $297.57 | +121.4% | Sep 19, 2024 |
| Barclays | Manav Patnaik | $380 | $297.77 | +171.4% | Sep 13, 2024 |
| New Street | Toni Kaplan | $271 | $297.99 | +93.6% | Sep 12, 2024 |
| Needham | Kyle Peterson | $350 | $305.12 | +150.0% | Aug 28, 2024 |
| Wells Fargo | Jason Haas | $340 | $283.59 | +142.9% | Aug 12, 2024 |
| Needham | Kyle Peterson | $320 | $265.9 | +128.6% | Jul 19, 2024 |
| Stifel Nicolaus | Shlomo Rosenbaum | $305 | $264.19 | +117.9% | Jul 19, 2024 |
| Oppenheimer | Owen Lau | $300 | $260.3 | +114.3% | Jul 19, 2024 |
| Goldman Sachs | George Tong | $277 | $264.19 | +97.9% | Jul 18, 2024 |
| Evercore ISI | David Togut | $305 | $272.15 | +117.9% | Jul 18, 2024 |
| Oppenheimer | Owen Lau | $272 | $217.51 | +94.3% | Apr 19, 2024 |
| Stifel Nicolaus | Shlomo Rosenbaum | $265 | $217.51 | +89.3% | Apr 19, 2024 |
| Robert W. Baird | Jeffrey Meuler | $260 | $217.51 | +85.7% | Apr 19, 2024 |
| Morgan Stanley | Toni Kaplan | $240 | $217.51 | +71.4% | Apr 18, 2024 |
| Stifel Nicolaus | Shlomo Rosenbaum | $295 | $262.74 | +110.7% | Apr 9, 2024 |
| Evercore ISI | David Togut | $310 | $247.94 | +121.4% | Feb 13, 2024 |
| Deutsche Bank | Faiza Alwy | $267 | $230.38 | +90.7% | Dec 7, 2023 |
| RBC Capital | Ashish Sabadra | $205 | $202.29 | +46.4% | Apr 21, 2023 |
| Truist Financial | Analyst unavailable | $260 | $222.56 | +85.7% | Feb 6, 2023 |
| Wells Fargo | Analyst unavailable | $210 | $217.56 | +50.0% | Jan 13, 2023 |
| Morgan Stanley | Analyst unavailable | $197 | $205.76 | +40.7% | Jan 4, 2023 |
| Stifel Nicolaus | Stifel Stifel | $222 | $192.63 | +58.6% | Dec 16, 2022 |
| J.P. Morgan | Analyst unavailable | $219 | $201.85 | +56.4% | Nov 18, 2022 |
| Atlantic Equities | Simon Clinch | $230 | $207.1 | +64.3% | Nov 15, 2022 |
| Needham | Analyst unavailable | $230 | $193.99 | +64.3% | Nov 14, 2022 |
| Morgan Stanley | Analyst unavailable | $212 | $172.07 | +51.4% | Sep 27, 2022 |
| Barclays | Analyst unavailable | $230 | $193.99 | +64.3% | Jul 27, 2022 |
| Deutsche Bank | Analyst unavailable | $221 | $201.22 | +57.9% | Jul 22, 2022 |
| Truist Financial | Andrew Jeffrey | $230 | $200.56 | +64.3% | Jul 22, 2022 |
| Morgan Stanley | Analyst unavailable | $230 | $200.56 | +64.3% | Jul 22, 2022 |
| Credit Suisse | Analyst unavailable | $245 | $200.52 | +75.0% | Jul 21, 2022 |
| Stifel Nicolaus | Analyst unavailable | $223 | $183.14 | +59.3% | Jul 1, 2022 |
| Morgan Stanley | Toni Kaplan | $227 | $184.94 | +62.1% | Jun 28, 2022 |
| Evercore ISI | David Togut | $200 | $203.52 | +42.9% | Apr 29, 2022 |
| Barclays | Analyst unavailable | $250 | $206.53 | +78.6% | Apr 22, 2022 |
| Credit Suisse | Analyst unavailable | $250 | $206.44 | +78.6% | Apr 22, 2022 |
| Deutsche Bank | Analyst unavailable | $225 | $202.95 | +60.7% | Apr 22, 2022 |
| Goldman Sachs | George Tong | $221 | $202.95 | +57.9% | Apr 21, 2022 |
| RBC Capital | Analyst unavailable | $244 | $221.41 | +74.3% | Apr 21, 2022 |
| Morgan Stanley | Toni Kaplan | $250 | $202.95 | +78.6% | Apr 21, 2022 |
| Needham | Kyle Peterson | $275 | $202.95 | +96.4% | Apr 21, 2022 |
| Robert W. Baird | Jeffrey Meuler | $281 | $221.41 | +100.7% | Apr 20, 2022 |
| Deutsche Bank | Faiza Alwy | $265 | $214.14 | +89.3% | Apr 18, 2022 |
| Barclays | Manav Patnaik | $300 | $235.46 | +114.3% | Mar 27, 2022 |
| Cowen & Co. | Georgios Mihalos | $295 | $228.23 | +110.7% | Jan 20, 2022 |
| BNP Paribas | George Gregory | $290 | $280.26 | +107.1% | Nov 22, 2021 |
| Jefferies | Hamzah Mazari | $320 | $274.74 | +128.6% | Nov 11, 2021 |
| Argus Research | David Coleman | $285 | $267.42 | +103.6% | Oct 22, 2021 |
| Goldman Sachs | George Tong | $267 | $248.56 | +90.7% | Jul 22, 2021 |
| Credit Suisse | Kevin Mcveigh | $270 | $220.02 | +92.9% | Apr 22, 2021 |
Track every rating change on EFX the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationEquifax Inc. operates as a global data and analytics company, delivering a range of information solutions and specialized human resources administrative process outsourcing services. Its clientele spans across businesses, governmental organizations, and individual consumers. The company's operations are structured into three primary divisions: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment specializes in employment-related data, offering verification services for income, employment history, criminal records, and Social Security numbers. It also provides tools for payroll-based transactions, employment tax management, and products aimed at protecting against identity theft. The U.S. Information Solutions (USIS) segment provides a comprehensive suite of services for both consumers and businesses within the United States.…
Historical context
All EFX earningsIndustrials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| CTAS Cintas Corporation | FY2027 Q1 · Calendar Q3 2026 | +3.0% | -3.4% | Cintas raises FY2027 guidance as Q1 growth broadens |
| PAYX Paychex, Inc. | FY2027 Q1 · Calendar Q3 2026 | +1.5% | -8.8% | Paychex maintains FY27 outlook as PEO and AI momentum strengthen |
| FPS Forgent Power Solutions, Inc. | FY2026 Q4 · Calendar Q3 2026 | +4.3% | +9.5% | Forgent Power Solutions pairs record results with an aggressive FY27 buildout |
| CPRT Copart, Inc. | FY2026 Q4 · Calendar Q3 2026 | -8.7% | -2.6% | Copart pairs international growth with ACV investment amid higher costs |
| SUNB Sunbelt Rentals Holdings Inc | FY2027 Q1 · Calendar Q3 2026 | +19.2% | +5.9% | Sunbelt raises FY27 outlook as specialty rental demand accelerates |
| FRO Frontline Plc | FY2026 Q2 · Calendar Q3 2026 | +8.0% | +1.0% | Frontline posts a record quarter as tanker rates remain elevated |
Latest beats and misses
Who reports nextBeat on EPS
- ACNFY2026 Q4 · October 1, 2026+3.5% EPS+15.8% move
- MKCFY2026 Q3 · October 1, 2026+13.9% EPS-4.9% move
- NKEFY2027 Q1 · October 1, 2026+10.0% EPS-0.7% move
- CAGFY2027 Q1 · September 30, 2026+44.4% EPS-4.9% move
- FDSFY2026 Q4 · September 30, 2026+3.9% EPS+3.8% move
- JBLFY2026 Q4 · September 30, 2026+8.1% EPS-10.0% move
Get the EFX recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:22.444131+00:00
- Polygon adjusted daily market bars · 2026-10-03T12:16:12.655229+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-03T12:16:12.652202+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-03. For educational purposes only; not investment advice.